Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA

Biochemical Journal

Volumn 405, Issue 1, 2007, Pages 41-49

  De Jonge, Jørgen ^a,c   Leenhouts, Johanna M ^b   Holtrop, Marijke ^a   Schoen, Pieter ^a,c   Scherrer, Peter ^b,d   Cullis, Pieter R ^b   Wilschut, Jan ^a   Huckriede, Anke ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Solvay Pharmaceuticals Inc   (Netherlands)

^d Inex Pharmaceuticals Corporation   (Canada)

Author keywords

Gene delivery; Haemagglutinin; Influenza virus; Plasmid DNA; Virosome

Indexed keywords

GENE DELIVERY; HAEMAGGLUTININ; INFLUENZA VIRUS; PLASMID DNA; VIROSOME;

CELL MEMBRANES; DNA; ENZYME ACTIVITY; PROTEINS; VIRUSES;

GENE TRANSFER;

CATION; DICAPROYLPHOSPHATIDYLCHOLINE; HEXANOIC ACID DERIVATIVE; NUCLEASE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PLASMID DNA; UNCLASSIFIED DRUG; VIROSOME; VIRUS SPIKE PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENE TRANSFER; INFLUENZA VIRUS; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; SUCROSE DENSITY GRADIENT CENTRIFUGATION; VIRAL GENE DELIVERY SYSTEM; VIRUS ENVELOPE;

ANIMALS; CELL LINE; GENE TRANSFER TECHNIQUES; ORTHOMYXOVIRIDAE; PLASMIDS; TRANSFECTION; VIROSOMES; VIRUS INTERNALIZATION;

ORTHOMYXOVIRIDAE;

EID: 34347213729     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20061756     Document Type: Article

References (50)

1. Kay, M. A., Glorioso, J. C. and Naldini, L. (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat. Med. 7, 33-40
2. Thomas, C. E., Ehrhardt, A. and Kay, M. A. (2003) Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4, 346-358
3. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E. et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419
4. Morral, N., O'Neal, W. K., Rice, K., Leland, M. M., Piedra, P. A., Aguilar-Cordova, E., Carey, K. D., Beaudet, A. L. and Langston, C. (2002) Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum. Gene Ther. 13, 143-154
5. Kafri, T., Morgan, D., Krahl, T., Sarvetnick, N., Sherman, L. and Verma, I. (1998) Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 95, 11377-11382
6. Schmidt-Wolf, G. D. and Schmidt-Wolf, I. G. (2003) Non-viral and hybrid vectors in human gene therapy: an update. Trends Mol. Med. 9, 67-72
7. Kumar, V. V., Singh, R. S. and Chaudhuri, A. (2003) Cationic transfection lipids in gene therapy: successes, set-backs, challenges and promises. Curr. Med. Chem. 10, 1297-1306
8. Dass, C. R. (2004) Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection. J. Mol. Med. 82, 579-591
9. Pedroso de Lima, M. C., Neves, S., Filipe, A., Duz̈günes, N. and Simoes, S. (2003) Cationic liposomes for gene delivery: from biophysics to biological applications. Curr. Med. Chem. 10, 1221-1231
10. Miller, A. D. (2003) The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy. Curr. Med. Chem. 10, 1195-1211
11. Gao, X. and Huang, L. (1991) A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179, 280-285
12. Porteous, D. J., Dorin, J. R., McLachlan, G., Davidson-Smith, H., Davidson, H., Stevenson, B. J., Carothers, A. D., Wallace, W. A., Moralee, S., Hoenes, C. et al. (1997) Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4, 210-218
13. Noone, P. G., Hohneker, K. W., Zhou, Z., Johnson, L. G., Foy, C., Gipson, C., Jones, K., Noah, T. L., Leigh, M. W., Schwartzbach, C. et al. (2000) Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol. Ther. 1, 105-114
14. Earp, L. J., Delos, S. E., Park, H. E. and White, J. M. (2004) The many mechanisms of viral membrane fusion proteins. Curr. Top. Microbiol. Immunol. 285, 25-66
15. Jardetzky, T. S. and Lamb, R. A. (2004) Virology: a class act. Nature 427, 307-308
16. Schoen, P., Chonn, A., Cullis, P. R., Wilschut, J. and Scherrer, P. (1999) Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles. Gene Ther. 6, 823-832
17. de Jonge, J., Holtrop, M., Wilschut, J. and Huckriede, A. (2006) Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs. Gene Ther. 13, 400-411
18. Correale, P., Cusi, M. G., Sabatino, M., Micheli, L., Pozzessere, D., Nencini, C., Valensin, P. E., Petrioli, R., Giorgi, G., Zurbriggen, R. et al. (2001)Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes. Eur. J. Cancer 37, 2097-2103
19. Daemen, T., deMare, A., Bungener, L., de Jonge, J., Huckriede, A. and Wilschut, J. (2005) Virosomes for antigen and DNA delivery. Adv. Drug Deliv. Rev. 57, 451-463
20. Ramani, K., Hassan, Q., Venkaiah, B., Hasnain, S. E. and Sarkar, D. P. (1998) Site-specific gene delivery in vivo through engineered Sendai viral envelopes. Proc. Natl. Acad. Sci. U.S.A. 95, 11886-11890
21. Ponimaskin, E., Bareesel, K. K., Markgraf, K., Reszka, R., Lehmann, K., Gelderblom, H. R., Gawaz, M. and Schmidt, M. F (2000) Sendai virosomes revisited: reconstitution with exogenous lipids leads to potent vehicles for gene transfer. Virology 269, 391-403
22. Shoji, J., Tanihara, Y., Uchiyama, T. and Kawai, A. (2004) Preparation of virosomes coated with the vesicular stomatitis virus glycoprotein as efficient gene transfer vehicles for animal cells. Microbiol. Immunol. 48, 163-174
23. Uchida, T., Kim, J., Yamaizumi, M., Miyake, Y. and Okada, Y., (1979) Reconstitution of lipid vesicles associated with HVJ (Sendai virus) spikes: purification and some properties of vesicles containing nontoxic fragment A of diphtheria toxin. J. Cell Biol. 80, 10-20
24. Stegmann, T., Morselt, H. W. M., Booy, F. P., Van Breemen, J. F. L., Scherphof, G. and Wilschut, J. (1987) Functional reconstitution of influenza virus envelopes. EMBO J. 6, 2651-2659
25. Paternostre, M., Viard, M., Meyer, O., Ghanam, M., Ollivon, M and Blumenthal, R. (1997) Solubilization and reconstitution of vesicular stomatitis virus envelope using octylglucoside. Biophys. J. 72, 1683-1694
26. Dzau, V. J., Mann, M. J., Morishita, R. and Kaneda, Y. (1996) Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc. Natl. Acad. Sci. U.S.A. 93, 11421-11425
27. Peterson, G. L. (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83, 346-356
28. Böttcher, C. J. P., van Gent, C., M. and Pries, C. (1961) A rapid and sensitive sub-micro phosphorus determination. Anal. Chim. Acta 24, 203-204
29. de Jonge, J., Schoen, P., ter Veer, W., Stegmann, T., Wilschut, J. and Huckriede, A. (2006) Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopes. Biochim. Biophys. Acta 1758, 527-536
30. Ferrari, M. E., Nguyen, C. M., Zelphati, O., Tsai, Y. and Feigner, P. L. (1998) Analytical methods for the characterization of cationic lipid-nucleic acid complexes. Hum. Gene Ther. 9, 341-351
31. Galla, H. J. and Hartmann, W. (1980) Excimer-forming lipids in membrane research, Chem. Phys. Lipids 27, 199-219
32. Stegmann, T., Schoen, P., Bron, R., Wey, J., Bartoldus, I., Ortiz, A., Nieva, J. L. and Wilschut, J. (1993) Evaluation of viral membrane-fusion assays: comparison of the octadecylrhodamine dequenching assay with the pyrene excimer assay. Biochemistry 32, 11330-11337
33. Bungener, L., Serre, K., Bijl, L., Leserman, L., Wilschut, J., Daemen, T. and Machy, P. (2002) Virosome-mediated delivery of protein antigens to dendritic cells. Vaccine 20, 2287-2295
34. Lamb, R. A. and Krug, R. M. (2001) Orthomyxoviridae: the viruses and their replication. In Fields Virology (Knipe D.M., Howley P. M., ed.), pp. 1487-1531, Lippincott Williams & Wilkins, Philadelphia
35. Puri, A., Booy, F. P., Doms, R. W., White, J. M. and Blumenthal, R. (1990) Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment. J. Virol. 64, 3824-3832
36. Ohkuma, S. and Poole, B. (1978) Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. U.S.A. 75, 3327-3331
37. Barry, M. E., Pinto-Gonzalez, D., Orson, F. M., McKenzie, G. J., Petry, G. R. and Barry, M. A. (1999) Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum. Gene Ther. 10, 2461-2480
38. Houk, B. E., Hochhaus, G. and Hughes, J. A. (1999) Kinetic modeling of plasmid DNA degradation in rat plasma. AAPS. PharmSci. 1, 1-6
39. Kawabata, K., Takakura, Y. and Hashida, M. (1995) The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Pharm. Res. 12, 825-830
40. Glasspool-Malone, J., Steenland, P. R., McDonald, R. J., Sanchez, R. A., Watts, T. L., Zabner, J. and Malone, R. W. (2002) DNA transfection of macaque and murine respiratory tissue is greatly enhanced by use of a nuclease inhibitor. J. Gene Med. 4, 323-322
41. Walther, W., Stein, U., Siegel, R., Fichtner, I. and Schlag, P. M. (2005) Use of the nuclease inhibitor aurintricarboxylic acid (ATA) for improved non-viral intratumoral in vivo gene transfer by jet-injection. J. Gene Med. 7, 477-485
42. Wheeler, J. J., Palmer, L., Ossanlou, M., MacLachlan, I., Graham, R. W., Zhang, Y. P., Hope, M. J., Scherrer, P. and Cullis, P. R. (1999) Stabilized plasmid-lipid particles: construction and characterization. Gene Ther. 6, 271-281
43. Saravolac, E. G., Ludkovski, O., Skirrow, R., Ossanlou, M., Zhang, Y. P., Giesbrecht, C., Thompson, J., Thomas, S., Stark, H., Cullis, P. R. and Scherrer, P. (2000) Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity. J. Drug Target 7, 423-437
44. Floch, V., Loisel, S., Guenin, E., Herve, A. C., Clement, J. C., Yaouanc, J. J., des Abbayes, H. and Ferec, C. (2000) Cation substitution in cationic phosphonolipids: a new concept to improve transfection activity and decrease cellular toxicity. J. Med. Chem. 43, 4617-4628
45. Ilies, M. A., Seitz, W. A. and Balaban, A. T. (2002) Cationic lipids in gene delivery: principles, vector design and therapeutical applications. Curr. Pharm. Des. 8, 2441-2473
46. Tamura, M., Webster, R. G. and Ennis, F. A. (1994) Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses. J. Virol. 68, 3499-3504
47. Chams, V., Bonnafous, P. and Stegmann, T. (1999) Influenza hemagglutinin mediated fusion of membranes containing poly(ethylene-glycol) grafted lipids: new insights into the fusion mechanism. FEBS Lett. 448, 28-32
48. Mastrobattista, E., Schoen, P., Wilschut, J., Crommelin, D. J. and Storm, G. (2001) Targeting influenza virosomes to ovarian carcinoma cells. FEBS Lett. 509, 71-76
49. Cusi, M. G., Terrosi, C., Savellini, G. G., Di Genova, G., Zurbriggen, R. and Correale, P. (2004) Efficient delivery of DNA to dendritic cells mediated by influenza virosomes. Vaccine 22, 735-739
50. Ochiai, H., Kurokawa, M., Matsui, S., Yamamoto, T., Kuroki, Y., Kishimoto, C. and Shiraki, K. (1992) Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody J. Med. Virol. 36, 217-221